"We analyzed efficacy and safety of imatinib in the first line therapy of 152 consecutive adult patients with chronic myeloid leukemia diagnosed in chronic phase from a defined region. We confirmed very good efficacy and safety of imatinib also in non-study patients treated in experienced centers. More appropriate selection of end-points in survival analyses is desirable to describe the real efficacy of imatinib and other TKIs." . "Cetkovsk\u00FD, Petr" . "American Journal of Hematology" . "Mu\u017E\u00EDk, J." . . . "B\u0159ezinov\u00E1, Jana" . . "[F48CBE764469]" . . "86" . "0361-8609" . "Dvo\u0159\u00E1kov\u00E1, D." . "We analyzed efficacy and safety of imatinib in the first line therapy of 152 consecutive adult patients with chronic myeloid leukemia diagnosed in chronic phase from a defined region. We confirmed very good efficacy and safety of imatinib also in non-study patients treated in experienced centers. More appropriate selection of end-points in survival analyses is desirable to describe the real efficacy of imatinib and other TKIs."@en . "Du\u0161ek, L." . . "Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?" . . . "R\u00E1zga, F." . "203573" . "4"^^ . "RIV/00023736:_____/11:00008834" . . "Moravcov\u00E1, Jana" . "Michalov\u00E1, Kyra" . "3" . . "R\u00E1\u010Dil, Z." . "Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?"@en . . "7"^^ . . "Posp\u00ED\u0161il, Z." . . "Mayer, J." . "10.1002/ajh.21942" . "18"^^ . . "Trn\u011Bn\u00FD, Marek" . . "Machov\u00E1 Pol\u00E1kov\u00E1, Kate\u0159ina" . "I, V" . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . . "http://dx.doi.org/10.1002/ajh.21942" . "\u017D\u00E1\u010Dkov\u00E1, D." . . . "000287670600017" . "Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?" . "Klamov\u00E1, Hana" . . "RIV/00023736:_____/11:00008834!RIV12-MZ0-00023736" . "Jur\u010Dek, T." . "Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?"@en . . "chronic myeloid leukemia; chronic phase; Imatinib"@en . . "Oltov\u00E1, A." . "Doubek, M." . .